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To stem the rising incidence of toxic exposure as well as the associated morbidity and mortality, the past century
has seen the establishment and evolution of poison control centers (PCCs) worldwide. Depending on the location,
PCCs vary in terms of staffing model, services offered, and funding sources. In this article, we discuss a survey of
poison control centers worldwide.Background
Poisonings are a major cause of morbidity and mortality
worldwide and as such represent a major public health
threat, especially to children, according to a World
Health Organization (WHO) report [1]. Potentially toxic
exposures can be pharmaceutical, chemical, occupa-
tional, or environmental in nature. Technological pro-
gress has hastened the rate at which novel chemicals are
developed and made available to the public, further rais-
ing the potential for adverse effects and outcomes. Our
ability to detect chemicals in the body and the environ-
ment has increased substantially over the past two dec-
ades; however, there is still a paucity of toxicology data
due to a lack of controlled data. According to the Cen-
ters for Disease Control and Prevention, deaths due to
poisoning surpassed deaths related to motor vehicle
accidents in the United States in 2008, and this trend
appears to be continuing [2].
To stem the rising incidence of toxic exposure as well
as the associated morbidity and mortality, the past cen-
tury has seen the establishment and evolution of poison
control centers (PCCs) worldwide. Depending on the lo-
cation, PCCs vary in terms of staffing model, services
offered, and funding sources. Numerous studies have
demonstrated the cost-effectiveness of PCCs in terms of
number of emergency department visits avoided and
decreased hospital length of stay [3-5]. In fact, an assess-
ment by the Institute of Medicine attributes $10 of po-
tential healthcare spending avoided for every $1 spent
on funding PCCs [6]. Additionally, the utilization of
PCCs has been associated with improved patient out-
comes [3-5].* Correspondence: Pourmand@gwu.edu
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In the United States, the American Association of Poi-
son Control Centers (AAPCC) oversees the nation’s 57
PCCs by providing accreditation as well as staff certifica-
tion and continuing education. Healthcare professionals
and the general public alike may solicit advice free of
charge from PCCs 24 hours a day, 365 days a year,
through a national telephone hotline [7]. PCC staff typ-
ically include nurses and pharmacists working under the
supervision of a board-certified medical toxicologist.
The certification process for PCC staff involves logging
at least 2,000 telephone encounter hours within a 12-
month period and passing a standardized examination.
Certified poison information specialists are also required
to perform continuing education activities as well as take
a re-certification exam every 7 years [8]. The AAPCC
also operates the National Poison Data System (NPDS),
a web-based software, which allows PCCs to upload in-
formation from telephone encounters in near real-time,
thereby functioning as a centralized database of expo-
sures as well as health outcomes [7,8]. This serves as a
valuable surveillance tool for identifying emerging public
health threats (e.g., drugs of abuse, medication and con-
sumer product adverse effects, bioterrorism) on a local,
regional, and national scale. Data is also available for epi-
demiologic research, and the AAPCC publishes an an-
nual report of exposures. Furthermore, the NPDS
contains a searchable compendium of toxicologic infor-
mation on approximately 390,000 chemicals, accessible
by PCC staff [8].
The nation’s 57 non-profit PCCs receive approximately
80 % of their funding from state disbursements and the
remainder from federal coffers, and occasionally specia-
lized contracts [9]. Budget cuts, however, threaten a re-
duction in staffing, services, and even the number oftral Ltd. This is an Open Access article distributed under the terms of the
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in operation, 3 closed in 2010 [8]. In 2011, federal ex-
penditure on PCCs decreased by 25 % alongside state-
level cuts [10]. The full magnitude of effect has yet to be
determined, but it is likely that monetary concerns will
have a significant impact on the practice of medical toxi-
cology in the United States.
Sweden
The Swedish Poisons Information Centre (SPIC), operat-
ing out of Karolinska University Hospital, serves as the
nation’s sole PCC and is staffed by pharmacists. SPIC
pharmacists field queries from the national telephone
hotline, accessible 24 hours daily by healthcare profes-
sionals and laypersons. These pharmacists receive a
minimum of 3 months of in-service training prior to
managing telephone encounters independently. Physi-
cians from several specialties, including toxicologists,
intensivists, and anesthesiologists, provide medical
supervision. The SPIC operates under the auspices of
Sweden’s Medical Product Agency and therefore receives
funding from the national government [11].
Japan
In Japan, toxicology has only emerged as a public health
priority in recent decades [12]. Founded in 1986, the
relatively nascent Japan Poison Information Center
(JPIC) operates two PCCs. Healthcare professionals and
the lay public may contact the Osaka PCC via telephone
24 hours daily and the Tsukuba PCC during regular
business hours (i.e., 0900 to 1700). Pharmacists with
post-graduate training in poison information staff each
PCC. The centers currently rely on affiliations with local
hospitals for medical support from physicians. Despite
receiving grants from Japan’s Ministry of Health and
Welfare, the Osaka PCC has struggled to meet the de-
mand of its telephone service due to budget constraints
and has therefore established priority telephone lines for
financial supporters, including private individuals,
healthcare professionals, hospitals, and industrial en-
tities. The Ministry of Health and Welfare also supports
the JPIC in the development and maintenance of a com-
puterized database of poison information [13].
Brazil
Brazil’s 36 regional PCCs, in operation 24 hours daily,
provide telephone consultations to healthcare profes-
sionals and the general public. The National Pharmaco-
Toxicological Information System provides poison
information support to the PCCs. Brazil also boasts a
rich academic climate fostered by the activities of the
Brazilian Society of Toxicology, which hosts a biennial
Brazilian Congress of Toxicology and promotes a myr-
iad of toxicology training opportunities ranging fromcertificate programs to doctoral degrees. As PCCs do
not technically belong to Brazil’s public healthcare sys-
tem, they do not receive funding from the national
government, and hence rely on volunteer staff and a
mélange of precarious funding sources, including local
governments as well as affiliated hospitals and univer-
sities [5,12].
United Kingdom
The United Kingdom’s National Poisons Information
Service (NPIS) operates 24 hours daily through 4 PCCs
[14]. Only registered healthcare professionals may ac-
cess NPIS programs, which include a telephone service
and a web-based poison information database, TOX-
BASE [14]. The general public may not directly access
NPIS programs; rather, laypersons may make inquiries
to the National Health Service via a telephone service
staffed by nurses with access to TOXBASE. Commis-
sioned by the national Health Protection Agency
(HPA), the NPIS receives funding primarily from gov-
ernment grants, but also generates some revenue
through research grants and the sale of TOXBASE sub-
scriptions to commercial entities approved by the HPA.
NPIS staff maintain TOXBASE, ensuring that its 14,000
product entries provide healthcare professionals with
up-to-date information to accurately diagnose and to
appropriately manage patient exposures [14]. Further-
more, TOXBASE serves as a training platform for med-
ical schools as well as healthcare professionals seeking
continuing education [1].
Iran
Iran currently operates 29 PCCs, or Drug and Poison In-
formation Centers (DPICs), with the support of its med-
ical universities and the Food and Drug Organization
[12]. DPICs respond via telephone, email, or fax to poi-
son information requests from healthcare professionals
and laypersons [15]. Qualified responders at DPICs in-
clude physicians and pharmacists trained in toxicology.
DPICs also disseminate poison information through lit-
erature publication and distribution, mass media cam-
paigns, seminars, and other continuing education
opportunities [12,15]. Healthcare professionals and the
general public alike may get advice free of charge from a
telephone hotline available in all parts of the country, 24
hours a day, 365 days a year, with calls routed to the
nearest DPIC. In addition to DPICs, Iran has seen the
development of numerous poison treatment centers
(PTCs) [16]. Typically based out of teaching hospitals,
PTCs are specialized in the management of clinical toxi-
cology and serve as repositories for antidotes [17], al-
though the majority of Iran’s emergency departments
and intensive care units also routinely handle cases of
poisoning [18]. In some instances, PTCs focus on
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Hospital’s expertise in scorpion and snake toxins in
southern Iran [16].Future directions
The interconnectedness of the global community begs
the need for greater collaboration in creating a consoli-
dated, international poison information database with
standardized treatment protocols. One of the major lim-
itations of the individual databases is that there is often
a paucity of data on foreign products, which will be an
emerging concern in a time of increasing global com-
merce. The International Programme on Chemical
Safety, a joint effort by the WHO, the International
Labour Organization, and the United Nations Environ-
ment Programme, in cooperation with the Canadian
Centre for Occupational Health and Safety, currently
maintains a web-based resource, INCHEM, which pro-
vides peer-reviewed chemical monographs to the public
at no charge. INCHEM, however, relies primarily on
contributions from Europe, such as the Commission of
the European Union, the Swedish Criteria Group, the
Nordic Expert Group, and the United Kingdom’s NPIS,
and conspicuously lacks the voluminous data amassed in
the United States’ NPDS [19]. A comprehensive patient
encounter database would equip PCCs worldwide with
an enhanced surveillance mechanism to more readily
recognize public health threats, such as emerging drugs
of abuse (e.g., bath salts, synthetic marijuana) [20].
Moreover, as some PCCs face challenges in obtaining
chemical profiles and monographs from industry and
manufacturing entities reluctant to voluntarily divulge
proprietary information, such as in Japan, the aforemen-
tioned organizations should leverage their international
influence to foster greater knowledge sharing [13].
With the emergence of mobile technology and social
media, PCCs should utilize these platforms for mass
marketing to more effectively disseminate public health
education and warnings. Additionally, mobile technology
may facilitate bringing critical poison information to the
bedside clinician.
PCCs worldwide struggle to secure stable sources of
funding, with most relying on a combination of govern-
mental support, grants, fundraising, and miscellaneous
contract income and subscription fees. Even in times of
fiscal austerity, governments should prioritize financial
support for PCCs, given the cost savings and improved
outcomes they provide.Competing interests
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